Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, elaborates on the role of supportive and palliative care in medical oncology

Published: 30 October 2017

Recent Videos

video

Jasmine Zain, MD, on the most exciting studies in lymphoma presented at ASH 2018

Dr. Zain, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, ...

video

Yana Pikman, MD, regarding research outcomes from the LEAP Consortium

Dr. Pikman, Instructor in Pediatrics, Dana Farber Cancer Institute, Boston Children’s Hospital, explains how the results of the LEAP Consortium’s ...

video

Jasmine Zain, MD, discusses novel treatment research regarding transplants at City of Hope

Dr. Zain, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, discusses ...

video

Jasmine Zain, MD, considers the impact of the new induction regimen in PTCL

Dr. Zain, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, ...

video

Yana Pikman, MD, on the efforts of the LEAP Consortium in pediatric acute leukemia

Dr. Pikman, Instructor in Pediatrics, Dana Farber Cancer Institute, Boston Children’s Hospital, explains the LEAP Consortium and how the group ...

video

Jasmine Zain, MD, defines successful induction regimens when treating PTCL

Dr. Zain, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, discusses ...

video

Jasmine Zain, MD, elaborates on the investigation of novel induction regimens in PTCL

Dr. Zain, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, tells ...

video

Jasmine Zain, MD, regarding the standard of care in treatment of PTCL

Dr. Zain, Associate Clinical Professor of Hematology & Hematopoietic Cell Transplantation, Director, T cell Lymphoma Program, City of Hope, explains ...

video

Carol Moreno, MD, PhD, discusses MRD as a legitimate surrogate marker in CLL

Dr. Moreno, Hematologist, University of Barcelona, considers whether minimal residual disease (MRD) is a legitimate surrogate marker for response and ...

video

Carol Moreno, MD, PhD, describes recent advancements in the treatment of CLL

Dr. Moreno, Hematologist, University of Barcelona, elaborates on recent advancements in the treatment of chronic lymphocytic leukemia (CLL)

Related Videos

video-image

Jasmine Zain, MD, elaborates on the investigation of novel induction regimens in PTCL

video-image

Jasmine Zain, MD, defines successful induction regimens when treating PTCL

video-image

Yana Pikman, MD, on the efforts of the LEAP Consortium in pediatric acute leukemia

video-image

Jasmine Zain, MD, considers the impact of the new induction regimen in PTCL

video-image

Jasmine Zain, MD, discusses novel treatment research regarding transplants at City of Hope

video-image

Yana Pikman, MD, regarding research outcomes from the LEAP Consortium

video-image

Jasmine Zain, MD, on the most exciting studies in lymphoma presented at ASH 2018

video-image

Jasmine Zain, MD, regarding the standard of care in treatment of PTCL

video-image

Rena Feinman, PhD, considers the the role of the microbiome in cancer & response to therapy

video-image

Jason Butler, PhD, considers how vascular integrity impacts the leukemia-initiating metabolic switch

video-image

Carol Moreno, MD, PhD, shares outcomes from the iLLUMINATE trial presented at ASH 2018

video-image

Rod A. Humerickhouse, MD, PhD, on MRD as a surrogate marker in chronic lymphocytic leukemia

video-image

Carol Moreno, MD, PhD, on how the outcomes of the illUMINTATE trial impact treatment of CLL

video-image

Rod A. Humerickhouse, MD, PhD, considers testing for minimal residual disease in CLL

video-image

Carol Moreno, MD, PhD, on the Phase 3 trial examining ibrutinib + rituximab versus FCR in CLL

video-image

Rod A. Humerickhouse, MD, PhD, describes recent advancements in the treatment of CLL

video-image

Sen Zhuang, MD, PhD, shares the research & development philosophy at Janssen

video-image

Carol Moreno, MD, PhD, describes recent advancements in the treatment of CLL

video-image

Rod A. Humerickhouse, MD, PhD, regarding potential side effects from venetoclax + rituximab in CLL

video-image

Carol Moreno, MD, PhD, discusses MRD as a legitimate surrogate marker in CLL